Elika Rad, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Elika Rad’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C17247 · Deceased
Licence status: Deceased · since 1955 · University of Illinois College of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$125,505
Pharmacies billed $125,505 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 19) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
0 generic and 14 brand-name prescriptions · $125,505 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 19 | None | 0% (0) | 74% | $125,505 |
| 2023 | 257 | 25 | 0% (0) | 75% | $3,738,059 |
| 2022 | 311 | 31 | None | 60% | $2,952,677 |
| 2021 | 191 | 26 | None | 64% | $1,849,409 |
| 2020 | 264 | 29 | 0% (0) | 57% | $1,586,077 |
| 2019 | 342 | 48 | None | None | $1,394,334 |
| 2018 | 583 | 52 | None | None | $1,024,933 |
| 2017 | 417 | 54 | None | None | $514,045 |
| 2016 | 334 | 33 | None | None | $483,167 |
| 2015 | 287 | 40 | None | None | $720,246 |
| 2014 | 236 | 25 | None | 44% | $375,275 |
| 2013 | 90 | 22 | 0% (0) | 41% | $95,008 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Trikafta | 90 | $2,517,882 | $27,976 |
| Symdeko | 17 | $458,267 | $26,957 |
| Kalydeco | 11 | $327,550 | $29,777 |
| Zenpep | 15 | $179,010 | $11,934 |
| Creon | 15 | $107,934 | $7,196 |
| Azithromycin | 14 | $484 | $35 |
| Albuterol Sulfate Hfa | 11 | $468 | $43 |
| Montelukast | 11 | $152 | $14 |
2022: 5 drugs
| Trikafta | 90 | $2,469,799 | $27,442 |
| Creon | 28 | $202,918 | $7,247 |
| Zenpep | 16 | $114,210 | $7,138 |
| Azithromycin | 32 | $1,052 | $33 |
| Famotidine | 13 | $113 | $9 |
2021: 2 drugs
| Trikafta | 61 | $1,551,279 | $25,431 |
| Azithromycin | 17 | $771 | $45 |
2020: 6 drugs
| Trikafta | 50 | $1,274,674 | $25,493 |
| Creon | 21 | $120,778 | $5,751 |
| Amitiza | 11 | $5,002 | $455 |
| Azithromycin | 15 | $686 | $46 |
| Montelukast | 25 | $241 | $10 |
| Pantoprazole | 15 | $68 | $5 |
2019: 8 drugs
| Symdeko | 27 | $626,386 | $23,199 |
| Kalydeco | 17 | $427,970 | $25,175 |
| Creon | 27 | $136,776 | $5,066 |
| Advair Diskus | 18 | $10,086 | $560 |
| Azithromycin | 20 | $1,098 | $55 |
| Pantoprazole | 28 | $230 | $8 |
| Ciprofloxacin | 12 | $129 | $11 |
| Montelukast | 18 | $114 | $6 |
2018: 18 drugs
| Symdeko | 14 | $322,706 | $23,050 |
| Creon | 16 | $130,371 | $8,148 |
| Noxafil | 16 | $101,896 | $6,369 |
| Cresemba | 13 | $63,236 | $4,864 |
| Sporanox | 23 | $31,165 | $1,355 |
| Valganciclovir | 24 | $25,440 | $1,060 |
| Itraconazole | 16 | $7,775 | $486 |
| Azithromycin | 41 | $1,394 | $34 |
| Azathioprine | 11 | $834 | $76 |
| Mycophenolate Mofetil | 19 | $705 | $37 |
| Pantoprazole | 34 | $451 | $13 |
| Diltiazem 24hr Er (Cd) | 19 | $377 | $20 |
| Montelukast | 30 | $267 | $9 |
| Sulfamethoxazole-Trimethoprim | 46 | $229 | $5 |
| Fluticasone Propionate | 18 | $227 | $13 |
| Prednisone | 12 | $142 | $12 |
| Alendronate | 13 | $75 | $6 |
| Carvedilol | 11 | $33 | $3 |
2017: 8 drugs
| Creon | 21 | $131,674 | $6,270 |
| Valganciclovir | 15 | $29,278 | $1,952 |
| Itraconazole | 11 | $2,059 | $187 |
| Azithromycin | 31 | $627 | $20 |
| Montelukast | 17 | $140 | $8 |
| Gabapentin | 12 | $105 | $9 |
| Sulfamethoxazole-Trimethoprim | 25 | $86 | $3 |
| Amlodipine Besylate | 12 | $29 | $2 |
2016: 9 drugs
| Creon | 12 | $69,739 | $5,812 |
| Valganciclovir | 20 | $59,595 | $2,980 |
| Advair Diskus | 16 | $9,495 | $593 |
| Symbicort | 12 | $3,486 | $290 |
| Azithromycin | 31 | $1,022 | $33 |
| Famotidine | 15 | $152 | $10 |
| Pantoprazole | 14 | $150 | $11 |
| Montelukast | 13 | $150 | $12 |
| Omeprazole | 13 | $45 | $3 |
2015: 6 drugs
| Kalydeco | 11 | $268,090 | $24,372 |
| Dronabinol | 12 | $7,531 | $628 |
| Amitiza | 12 | $5,069 | $422 |
| Azithromycin | 28 | $1,100 | $39 |
| Levofloxacin | 17 | $246 | $14 |
| Prednisone | 18 | $147 | $8 |
2014: 3 drugs
| Dronabinol | 17 | $7,527 | $443 |
| Combivent Respimat | 13 | $2,680 | $206 |
| Azithromycin | 24 | $1,165 | $49 |
Money from drug and device companies
$14 in 2022
A payment is not proof that care is biased.
| Chiesi USA | Bronchitol | $14 | 1 payment
|
See the published payment
| Chiesi USA | Education · 2022-01-10 | Bronchitol | $14 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1952621930
- Licence
- CA 17247California C17247: Deceased
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-06-01
- NPI last updated
- 2023-04-25
- NPI record certified
- 2023-04-25
This is when the NPI record was last certified, not a medical board exam.